{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:25:03Z","timestamp":1776119103155,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T00:00:00Z","timestamp":1557705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israeli Science Foundation","doi-asserted-by":"crossref","award":["544\/18"],"award-info":[{"award-number":["544\/18"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The thiazolidinedione (<jats:styled-content style=\"fixed-case\">TZD<\/jats:styled-content>) class of Peroxisome proliferator\u2010activated receptor gamma agonists has restricted clinical use for diabetes mellitus due to fluid retention and potential cardiovascular risks. These side effects are attributed in part to direct salt\u2010retaining effect of <jats:styled-content style=\"fixed-case\">TZD<\/jats:styled-content>s at the renal collecting duct. A recent study from our group revealed that prolonged rosiglitazone (<jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content>) treatment caused no Na+\/H<jats:sub>2<\/jats:sub>O retention or up\u2010regulation of Na<jats:sup>+<\/jats:sup> transport\u2010linked channels\/transporters in experimental congestive heart failure (<jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content>) induced by surgical aorto\u2010caval fistula (<jats:styled-content style=\"fixed-case\">ACF<\/jats:styled-content>). The present study examines the effects of <jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content> on renal and cardiac responses to atrial natriuretic peptide (<jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content>), Acetylcholine (Ach) and S\u2010Nitroso\u2010<jats:italic>N<\/jats:italic>\u2010acetylpenicillamine (<jats:styled-content style=\"fixed-case\">SNAP<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">NO<\/jats:styled-content> donor). Furthermore, we assessed the impact of <jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content> on gene expression related to the <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> signalling pathway in animals with <jats:styled-content style=\"fixed-case\">ACF<\/jats:styled-content>. Rats subjected to <jats:styled-content style=\"fixed-case\">ACF<\/jats:styled-content> (or sham) were treated with either <jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content> (30\u00a0mg\/kg\/day) or vehicle for 4\u00a0weeks. Cardiac chambers pressures and volumes were assessed invasively via Miller catheter. Kidney excretory and renal hemodynamic in response to <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content>, Ach and <jats:styled-content style=\"fixed-case\">SNAP<\/jats:styled-content> were examined. Renal clearance along with cyclic guanosine monophosphate (<jats:styled-content style=\"fixed-case\">cGMP<\/jats:styled-content>), gene expression of renal <jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content>\u2010related genes and <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> signalling in the kidney were determined. <jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content>\u2010treated <jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content> rats exhibited significant improvement in the natriuretic responses to <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> infusion. This \u2018sensitization\u2019 to <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> was not associated with increases in neither urinary <jats:styled-content style=\"fixed-case\">cGMP<\/jats:styled-content> nor in vitro <jats:styled-content style=\"fixed-case\">cGMP<\/jats:styled-content> production. However, <jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content> caused down\u2010regulation of several genes in the renal cortex (Ace, Nos3 and Npr1) and up\u2010regulation of <jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>2, Agtrla, Mme and Cftr along down\u2010regulation of Avpr2, Npr1,2, Nos3 and Pde3 in the medulla. In conclusion, <jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content>+<jats:styled-content style=\"fixed-case\">RGZ<\/jats:styled-content> rats exhibited significant enhancement in the natriuretic responses to <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> infusion, which are known to be blunted in <jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content>. This \u2018sensitization\u2019 to <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> is independent of <jats:styled-content style=\"fixed-case\">cGMP<\/jats:styled-content> signalling, yet may involve post\u2010<jats:styled-content style=\"fixed-case\">cGMP<\/jats:styled-content> signalling target genes such as <jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">CFTR<\/jats:styled-content> and V2 receptor. The possibility that <jats:styled-content style=\"fixed-case\">TZD<\/jats:styled-content> treatment in uncomplicated <jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content> may be less detrimental than thought before deserves additional investigations.<\/jats:p>","DOI":"10.1111\/jcmm.14366","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T05:59:36Z","timestamp":1557813576000},"page":"4779-4794","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure"],"prefix":"10.1111","volume":"23","author":[{"given":"Ilia","family":"Goltsman","sequence":"first","affiliation":[{"name":"Department of Physiology Bruce Rappaport Faculty of Medicine Technion\u2010IIT Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad E.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Physiology Bruce Rappaport Faculty of Medicine Technion\u2010IIT Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Aronson","sequence":"additional","affiliation":[{"name":"Department of Cardiology Rambam Health Care Campus Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omri","family":"Nativ","sequence":"additional","affiliation":[{"name":"Department of Physiology Bruce Rappaport Faculty of Medicine Technion\u2010IIT Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora Z.","family":"Feuerstein","sequence":"additional","affiliation":[{"name":"Department of Cardiology Rambam Health Care Campus Haifa Israel"},{"name":"FARMACON LLC, Translational Medicine Company Bryn Mawr Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Winaver","sequence":"additional","affiliation":[{"name":"Department of Physiology Bruce Rappaport Faculty of Medicine Technion\u2010IIT Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-197X","authenticated-orcid":false,"given":"Zaid","family":"Abassi","sequence":"additional","affiliation":[{"name":"Department of Physiology Bruce Rappaport Faculty of Medicine Technion\u2010IIT Haifa Israel"},{"name":"Department of Laboratory Medicine Rambam Health Care Campus Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,5,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.300268"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.302254"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.11.013"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/15733998113099990065"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1187"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7144"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.018"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2005.08.001"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730090-00002"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000313720"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810273191705"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810203191606"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.04.004"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00245-0"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1988.49"},{"issue":"4","key":"e_1_2_8_17_1","first-page":"H1441","article-title":"Neural influences on renal responses to acute volume expansion in rats with heart failure","volume":"271","author":"Patel KP","year":"1996","journal-title":"Am J Physiol"},{"issue":"5","key":"e_1_2_8_18_1","first-page":"III164","article-title":"Unifying hypothesis of sodium and water regulation in health and disease","volume":"18","author":"Schrier RW","year":"1991","journal-title":"Hypertension"},{"issue":"4","key":"e_1_2_8_19_1","first-page":"H1187","article-title":"Neurohumoral modulators and sodium balance in experimental heart failure","volume":"264","author":"Villarreal D","year":"1993","journal-title":"Am J Physiol"},{"issue":"5","key":"e_1_2_8_20_1","first-page":"R1599","article-title":"Effects of renal denervation on postprandial sodium excretion in experimental heart failure","volume":"266","author":"Villarreal D","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.09.007"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.110.960179"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00737.2004"},{"issue":"5","key":"e_1_2_8_24_1","first-page":"R776","article-title":"Hormonal determinants of sodium excretion in rats with experimental high\u2010output heart failure","volume":"254","author":"Winaver J","year":"1988","journal-title":"Am J Physiol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.32.4.746"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.10.3655"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(85)81105-4"},{"issue":"4","key":"e_1_2_8_28_1","first-page":"R858","article-title":"Atrial natriuretic peptide and renal cGMP in rats with experimental heart failure","volume":"261","author":"Abassi Z","year":"1991","journal-title":"Am J Physiol"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2008.12.011"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"issue":"29","key":"e_1_2_8_32_1","first-page":"729","article-title":"A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics","volume":"33","author":"Fuhr J","year":"1955","journal-title":"Klin Wochenschr"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01222.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000111587.51185.fe"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00362.2004"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000039963.01288.D3"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1081\/CEH-100100079"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2006.08.001"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2007.09.030"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00583.2007"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-68964-5_2"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00284.2007"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1159\/000093783"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.058008"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.18"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/1071-9164(94)90010-8"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.491"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000104834"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.137745"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01111"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01186.2004"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcmm.14366","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.14366","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcmm.14366","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.14366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T10:17:16Z","timestamp":1711016236000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcmm.14366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,13]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1111\/jcmm.14366"],"URL":"https:\/\/doi.org\/10.1111\/jcmm.14366","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,13]]},"assertion":[{"value":"2018-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}